Cutera (NASDAQ:CUTR) reported quarterly sales of $64.20 million which beat the analyst consensus estimate of $63.42 million by 1.23 percent. This is a 9.58 percent increase over sales of $58.59 million the same period last year.
HC Wainwright & Co. Maintains Buy on Albireo Pharma, Raises Price Target to $68
HC Wainwright & Co. analyst Ed Arce maintains Albireo Pharma (NASDAQ:ALBO) with a Buy and raises the price target from $54 to $68.